annual accounts payable:
$1.61M+$843.00K(+109.20%)Summary
- As of today (September 16, 2025), PTGX annual accounts payable is $1.61 million, with the most recent change of +$843.00 thousand (+109.20%) on December 31, 2024.
- During the last 3 years, PTGX annual accounts payable has risen by +$15.00 thousand (+0.94%).
- PTGX annual accounts payable is now -71.72% below its all-time high of $5.71 million, reached on December 31, 2018.
Performance
PTGX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$3.25M+$332.00K(+11.38%)Summary
- As of today (September 16, 2025), PTGX quarterly accounts payable is $3.25 million, with the most recent change of +$332.00 thousand (+11.38%) on June 30, 2025.
- Over the past year, PTGX quarterly accounts payable has dropped by -$380.00 thousand (-10.47%).
- PTGX quarterly accounts payable is now -83.17% below its all-time high of $19.30 million, reached on June 30, 2021.
Performance
PTGX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTGX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +109.2% | -10.5% |
| 3 y3 years | +0.9% | +117.8% |
| 5 y5 years | -42.1% | -15.8% |
PTGX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | +109.2% | -31.6% | +319.2% |
| 5 y | 5-year | -55.6% | +109.2% | -83.2% | +319.2% |
| alltime | all time | -71.7% | +362.8% | -83.2% | >+9999.0% |
PTGX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $3.25M(+11.4%) |
| Mar 2025 | - | $2.92M(+80.6%) |
| Dec 2024 | $1.61M(+109.2%) | $1.61M(-47.0%) |
| Sep 2024 | - | $3.05M(-16.0%) |
| Jun 2024 | - | $3.63M(+3.4%) |
| Mar 2024 | - | $3.51M(+352.9%) |
| Dec 2023 | $772.00K(-78.8%) | $775.00K(-38.2%) |
| Sep 2023 | - | $1.25M(-72.6%) |
| Jun 2023 | - | $4.58M(+13.4%) |
| Mar 2023 | - | $4.04M(+9.0%) |
| Dec 2022 | $3.64M(+127.5%) | $3.71M(-21.9%) |
| Sep 2022 | - | $4.75M(+218.2%) |
| Jun 2022 | - | $1.49M(-80.2%) |
| Mar 2022 | - | $7.54M(+201.7%) |
| Dec 2021 | $1.60M(-48.0%) | $2.50M(+36.8%) |
| Sep 2021 | - | $1.83M(-90.5%) |
| Jun 2021 | - | $19.30M(+102.0%) |
| Mar 2021 | - | $9.55M(+64.5%) |
| Dec 2020 | $3.08M | $5.81M(+19.1%) |
| Sep 2020 | - | $4.87M(+26.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $3.86M(-20.0%) |
| Mar 2020 | - | $4.82M(+19.0%) |
| Dec 2019 | $2.79M(-51.1%) | $4.05M(+55.7%) |
| Sep 2019 | - | $2.60M(-27.6%) |
| Jun 2019 | - | $3.60M(-53.1%) |
| Mar 2019 | - | $7.67M(+34.2%) |
| Dec 2018 | $5.71M(+354.3%) | $5.71M(+1.3%) |
| Sep 2018 | - | $5.63M(+120.6%) |
| Jun 2018 | - | $2.55M(+51.5%) |
| Mar 2018 | - | $1.69M(+34.1%) |
| Dec 2017 | $1.26M(+8.1%) | $1.26M(-44.6%) |
| Sep 2017 | - | $2.27M(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $1.16M(-6.7%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $1.89M(+51.6%) |
| Dec 2015 | $1.25M(+257.3%) | $1.25M |
| Dec 2014 | $349.00K | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Protagonist Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of PTGX is $1.61M
What is the all time high annual accounts payable for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual accounts payable is $5.71M
What is Protagonist Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, PTGX annual accounts payable has changed by +$843.00K (+109.20%)
What is Protagonist Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of PTGX is $3.25M
What is the all time high quarterly accounts payable for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly accounts payable is $19.30M
What is Protagonist Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, PTGX quarterly accounts payable has changed by -$380.00K (-10.47%)